Table 4.
Modification of the effect of avoiding NMBA in the analysis excluding patients who underwent intubation during CPR
Using NMBA | Avoiding NMBA | OR (95% CI); within strata of risk status | p value | |||||
---|---|---|---|---|---|---|---|---|
n with/without outcome | OR (95% CI) | p value | n with/without outcome | OR (95% CI) | p value | |||
Low risk | 16/233 | Reference | 3/16 | 1.69 (0.37–7.72) | 0.50 | 1.69 (0.37–7.72) | 0.50 | |
High risk | 29/87 | 3.99 (1.94–8.18) | < 0.001 | 8/9 | 11.45 (3.56–36.82) | < 0.001 | 3.24 (1.04–10.07) | 0.04 |
ORs are adjusted for age, sex, neck mobility limitation, abnormal facial shape, airway obstruction
High-risk status: post cardiac arrest, cerebral bleeding, infection of the central nervous system, epilepsy, convulsion, altered mental status (e.g. metabolic encephalopathy), spinal cord injury, traumatic brain injury, and respiratory disease
CPR cardiopulmonary resuscitation, NMBA neuromuscular blocking agent, OR odds ratio, CI confidence interval